Lv71
4240 积分 2022-09-18 加入
Peripheral NK cells identified as the predictor of response in extensive-stage small cell lung cancer patients treated with first-line immunotherapy plus chemotherapy
1个月前
已完结
532MO A phase Ib study of TQB2450 in combination with anlotinib in patients with advanced solid tumour
2个月前
已完结
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
2个月前
已完结
Prognostic significance of novel inflammatory markers in extensive-stage small-cell lung cancer
3个月前
已完结
Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum-based chemotherapy
3个月前
已完结
Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report
4个月前
已完结
Prognostic biomarkers and immune cell infiltration characteristics in small cell lung cancer
4个月前
已完结
A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer
4个月前
已完结
Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line – Results from the prospective German TLK cohort study
4个月前
已完结
皖公网安备34019202002308
